摘要: Monoclonal antibodies (MABs) are an exciting development in the field of clinical immunology. Secreted large amounts from hybrid myeloma (hybridoma) cell lines, MABs directed at a specific antigen, such as tumor antigens, providing major advantage over conventional, heterogeneous antisera. have shown promise treatment cancer, producing remission some patients with leukemia and lymphoma. The future uses enormous, including passive immunization against infections allergies, autoimmune disease, antibody drug intoxications. impact MAB technology on medicine will be felt years to come.
sagepub.com
sci-hub.se 参考文章(5)
Lennart Olsson, Monoclonal antibodies in clinical immunobiology. Derivation, potential, and limitations. Allergy. ,vol. 38, pp. 145- 154 ,(1983) , 10.1111/J.1398-9995.1983.TB01599.X
G. KÖHLER, C. MILSTEIN, Continuous cultures of fused cells secreting antibody of predefined specificity Nature. ,vol. 256, pp. 495- 497 ,(1975) , 10.1038/256495A0
K Sikora, Monoclonal antibodies in oncology. Journal of Clinical Pathology. ,vol. 35, pp. 369- 375 ,(1982) , 10.1136/JCP.35.4.369
P. J. THURLOW, I. F. C. MckENZIE, Monoclonal antibodies in clinical medicine--a review. Australian and New Zealand Journal of Medicine. ,vol. 13, pp. 91- 100 ,(1983) , 10.1111/J.1445-5994.1983.TB04563.X
Betty Diamond, Monoclonal Antibodies JAMA: The Journal of the American Medical Association. ,vol. 248, pp. 3165- None ,(1982) , 10.1001/JAMA.1982.03330230065038